On Tuesday, March 25, the Office of Information Technology will upgrade the GlobalProtect VPN client.
A service disruption on campus brought down many University services and applications for much of Thursday, though the issue ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small ...
13d
MedPage Today on MSNOmalizumab Superior to Oral Immunotherapy for Kids With Multi-Food AllergyOmalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food ...
Clinical trial shows omalizumab (Xolair) treats multiple severe food allergies more effectively than oral immunotherapy, with ...
OIT to discontinue support for phone and SMS multi-factor authentication, require Duo or Duke Unlock
For community members who currently rely on SMS messages or phone calls for multi-factor authentication (MFA), OIT instructs ...
Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to results from Stage 2 of ...
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
The study suggests that omalizumab could become a safer, more effective alternative to OIT for people with highly sensitive ...
News Medical on MSN14d
Omalizumab treats multi-food allergy better than oral immunotherapyThe high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results